How things get complicated

Pre-biotic evolution created something almost infinitely unlikely to have arisen by chance: reproducing entities whose many parts interact in a way that is vastly more complex and interdependent than the disorganized interactions of the inanimate objects in the surrounding environment. And yet this creation of primitive organisms was all achieved in perhaps a few hundred million years. In the January 16 Proceedings of the National Academy of Sciences, Jain and Krishna use mathematical modeling t

Written byWilliam Wells
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Pre-biotic evolution created something almost infinitely unlikely to have arisen by chance: reproducing entities whose many parts interact in a way that is vastly more complex and interdependent than the disorganized interactions of the inanimate objects in the surrounding environment. And yet this creation of primitive organisms was all achieved in perhaps a few hundred million years. In the January 16 Proceedings of the National Academy of Sciences, Jain and Krishna use mathematical modeling to propose that this creation event was no freak occurrence, as complexity and stability evolve rapidly and inevitably from interacting systems (Proc Natl Acad Sci USA 2001, 98:543-547). Their model involves a matrix of nodes, where each node could represent a chemical, species or element of human society. The nodes are given arbitrary starting populations, and random connections, with some connections positive (node A causes an increase in the population of node B) and others negative. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies